Trans-Resveratrol: Benefits, Dose and Healthy-Ageing Guide

The direct answer: trans-resveratrol is a plant polyphenol found in foods such as grapes and also supplied in concentrated supplement form. Human research is extensive, but outcomes vary widely by dose, population, duration and endpoint. There is currently no conclusive clinical evidence supporting resveratrol as a treatment or universal healthy-ageing intervention.

A useful supplement guide should therefore focus on the exact form, dose, source, human evidence, bioavailability limitations and medication considerations rather than treating resveratrol as a proven longevity compound.

What is trans-resveratrol?

Resveratrol is a stilbene polyphenol. It can exist in cis and trans forms; trans-resveratrol is the form most commonly used in supplements and clinical research.

Many commercial products use Japanese knotweed (Polygonum cuspidatum) as the source. Source and standardisation matter because “300mg extract” is not necessarily the same as 300mg trans-resveratrol.

What does the human evidence show?

A 2024 systematic review surveyed almost 200 clinical studies across at least 24 indications. The authors found an expanding body of human research but concluded that there was no conclusive clinical evidence to recommend resveratrol in any healthcare setting and that larger, higher-quality trials with clearly defined endpoints are still needed.

That is a much stronger summary than choosing one positive trial. Resveratrol has been studied across metabolic, cardiovascular, inflammatory, cognitive and other questions, but a result in one population should not be generalised to healthy consumers or to “anti-ageing” as a single outcome.

What about healthy ageing and longevity?

Preclinical research links resveratrol with pathways involved in stress responses and sirtuin biology. Those mechanisms helped create the longevity narrative around the ingredient.

Mechanistic plausibility is not the same as human lifespan evidence. There is no basis for claiming that taking a resveratrol supplement extends human lifespan, reverses ageing or reproduces calorie-restriction biology in a predictable way.

How well is oral resveratrol absorbed?

Resveratrol is absorbed from the gut, but it is rapidly metabolised into sulfate and glucuronide conjugates. Classic human pharmacokinetic work found high absorption with very low circulating bioavailability of unchanged resveratrol.

This is why a large number on the label should not automatically be interpreted as a proportionally larger concentration of unchanged trans-resveratrol in blood or tissues.

What dose has been studied?

Human trials use a very wide range of doses. The 2024 systematic review found substantial variation across studies and no consensus treatment regimen for a given condition or endpoint.

The review also reported that resveratrol has generally been well tolerated in study settings at doses up to around 1g/day, but this should not be turned into a personal safe-dose recommendation. Study populations and durations vary, and medication or medical conditions can change the risk picture.

Where Ayaani’s 300mg fits

Ayaani Liposomal NAD+ with Resveratrol provides 300mg trans-resveratrol from a 98% Polygonum cuspidatum root extract in the complete two-capsule daily serving.

It is paired with 1,200mg direct NAD+. The 300mg amount sits within the broad range seen across human resveratrol research, but that does not mean the finished combination has been clinically proven for a healthy-ageing endpoint.

Why pair resveratrol with NAD+?

The pairing has a mechanistic rationale because both ingredients appear in research around cellular metabolism and sirtuin-related pathways. Human evidence has not established that direct NAD+ plus trans-resveratrol creates a clinically proven synergy or produces a greater longevity effect than either ingredient alone.

Read What Does an NAD+ Supplement Do? for the distinction between direct NAD+, NR and NMN.

What about medication interactions?

Resveratrol and its metabolites can interact with drug-metabolising enzymes and transporters in laboratory studies, and reviews describe potential drug-interaction concerns at supplemental doses. This does not mean every interaction will be clinically important, but it is a reason not to treat a concentrated botanical-style ingredient as automatically risk-free.

The Food Standards Agency advises people taking regular prescribed medication to check with a healthcare professional before using a food supplement. This is particularly important when a medicine has a narrow therapeutic range or when blood-thinning, surgery or other interaction-sensitive circumstances are involved.

Seven checks before choosing resveratrol

1. Confirm trans-resveratrol. Do not compare a botanical-extract weight with a declared trans-resveratrol amount.
2. Check the source and standardisation.
3. Read the complete daily serving.
4. Separate mechanism from outcome evidence.
5. Do not assume better absorption from marketing language alone.
6. Review medication and medical circumstances.
7. Reject lifespan-extension, disease-treatment or age-reversal promises.

Frequently asked questions

Is trans-resveratrol proven for longevity?

No. Human clinical research is broad but does not establish lifespan extension or a universal healthy-ageing benefit.

Is 300mg a clinically proven ideal dose?

No. Human studies use widely varying doses, and there is no consensus regimen for a general healthy-ageing outcome.

Does Japanese knotweed mean the product is 98% resveratrol?

Not necessarily. The product specification must state the standardisation. Ayaani’s current formula declares 300mg trans-resveratrol from 98% Polygonum cuspidatum root extract.

Can resveratrol interact with medicine?

Potential interactions are biologically plausible and supported by pharmacokinetic research. Seek professional advice when taking prescribed medicine rather than assuming compatibility.

The bottom line

Trans-resveratrol is a well-studied polyphenol with an interesting but heterogeneous human evidence base. Choose it by exact trans-resveratrol amount, source, evidence and suitability. Treat “longevity”, “sirtuin activation” and “anti-ageing” as research context rather than guaranteed consumer outcomes.

References and further reading

1. Brown K et al. Resveratrol for the Management of Human Health: systematic review of clinical trials. PubMed.
2. Walle T et al. High absorption but very low bioavailability of oral resveratrol in humans. PubMed.
3. Poór M et al. Resveratrol metabolites and drug-transport/metabolism interactions. PubMed.
4. Food Standards Agency. Food supplements guidance. GOV.UK.

About the author
Ayaani Wellness Team creates practical, evidence-aware guidance to help readers make more informed supplement choices.